S&P 500   3,378.05 (+1.33%)
DOW   27,948.26 (+0.94%)
QQQ   270.92 (+2.16%)
AAPL   446.95 (+2.16%)
MSFT   207.45 (+2.00%)
FB   262.07 (+2.32%)
GOOGL   1,505.47 (+1.68%)
AMZN   3,143.01 (+2.02%)
NVDA   450.14 (+3.72%)
CGC   17.19 (+1.42%)
BABA   253.43 (+2.02%)
TSLA   1,498.63 (+9.04%)
GE   6.66 (-1.04%)
MU   47.99 (+0.48%)
AMD   80.84 (+5.15%)
T   30.23 (+0.10%)
F   7.17 (-0.83%)
ACB   9.90 (-1.20%)
GILD   68.81 (+1.04%)
NFLX   477.27 (+2.21%)
DIS   132.06 (+1.20%)
BAC   27.03 (+0.41%)
BA   178.35 (-0.99%)
S&P 500   3,378.05 (+1.33%)
DOW   27,948.26 (+0.94%)
QQQ   270.92 (+2.16%)
AAPL   446.95 (+2.16%)
MSFT   207.45 (+2.00%)
FB   262.07 (+2.32%)
GOOGL   1,505.47 (+1.68%)
AMZN   3,143.01 (+2.02%)
NVDA   450.14 (+3.72%)
CGC   17.19 (+1.42%)
BABA   253.43 (+2.02%)
TSLA   1,498.63 (+9.04%)
GE   6.66 (-1.04%)
MU   47.99 (+0.48%)
AMD   80.84 (+5.15%)
T   30.23 (+0.10%)
F   7.17 (-0.83%)
ACB   9.90 (-1.20%)
GILD   68.81 (+1.04%)
NFLX   477.27 (+2.21%)
DIS   132.06 (+1.20%)
BAC   27.03 (+0.41%)
BA   178.35 (-0.99%)
S&P 500   3,378.05 (+1.33%)
DOW   27,948.26 (+0.94%)
QQQ   270.92 (+2.16%)
AAPL   446.95 (+2.16%)
MSFT   207.45 (+2.00%)
FB   262.07 (+2.32%)
GOOGL   1,505.47 (+1.68%)
AMZN   3,143.01 (+2.02%)
NVDA   450.14 (+3.72%)
CGC   17.19 (+1.42%)
BABA   253.43 (+2.02%)
TSLA   1,498.63 (+9.04%)
GE   6.66 (-1.04%)
MU   47.99 (+0.48%)
AMD   80.84 (+5.15%)
T   30.23 (+0.10%)
F   7.17 (-0.83%)
ACB   9.90 (-1.20%)
GILD   68.81 (+1.04%)
NFLX   477.27 (+2.21%)
DIS   132.06 (+1.20%)
BAC   27.03 (+0.41%)
BA   178.35 (-0.99%)
S&P 500   3,378.05 (+1.33%)
DOW   27,948.26 (+0.94%)
QQQ   270.92 (+2.16%)
AAPL   446.95 (+2.16%)
MSFT   207.45 (+2.00%)
FB   262.07 (+2.32%)
GOOGL   1,505.47 (+1.68%)
AMZN   3,143.01 (+2.02%)
NVDA   450.14 (+3.72%)
CGC   17.19 (+1.42%)
BABA   253.43 (+2.02%)
TSLA   1,498.63 (+9.04%)
GE   6.66 (-1.04%)
MU   47.99 (+0.48%)
AMD   80.84 (+5.15%)
T   30.23 (+0.10%)
F   7.17 (-0.83%)
ACB   9.90 (-1.20%)
GILD   68.81 (+1.04%)
NFLX   477.27 (+2.21%)
DIS   132.06 (+1.20%)
BAC   27.03 (+0.41%)
BA   178.35 (-0.99%)
Log in

NASDAQ:AVGRAvinger Stock Price, Forecast & News

$0.52
-0.01 (-1.75 %)
(As of 08/12/2020 11:36 AM ET)
Add
Compare
Today's Range
$0.50
Now: $0.52
$0.54
50-Day Range
$0.29
MA: $0.39
$0.57
52-Week Range
$0.24
Now: $0.52
$1.84
Volume65,951 shs
Average Volume12.05 million shs
Market Capitalization$28.39 million
P/E RatioN/A
Dividend YieldN/A
Beta1.47
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat, and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. The company sells and markets its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.
Read More
Avinger logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.32 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AVGR
CUSIPN/A
Phone650-241-7900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$9.13 million
Book Value$0.14 per share

Profitability

Net Income$-19,450,000.00
Net Margins-225.26%

Miscellaneous

EmployeesN/A
Market Cap$28.39 million
Next Earnings Date11/3/2020 (Estimated)
OptionableNot Optionable
$0.52
-0.01 (-1.75 %)
(As of 08/12/2020 11:36 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AVGR News and Ratings via Email

Sign-up to receive the latest news and ratings for AVGR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Avinger (NASDAQ:AVGR) Frequently Asked Questions

How has Avinger's stock been impacted by COVID-19 (Coronavirus)?

Avinger's stock was trading at $0.43 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, AVGR stock has increased by 21.5% and is now trading at $0.5225.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Avinger?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avinger in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Avinger
.

When is Avinger's next earnings date?

Avinger is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Avinger
.

How were Avinger's earnings last quarter?

Avinger Inc (NASDAQ:AVGR) posted its quarterly earnings results on Thursday, July, 30th. The medical device company reported ($0.18) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.21) by $0.03. Avinger had a negative net margin of 225.26% and a negative return on equity of 283.92%.
View Avinger's earnings history
.

When did Avinger's stock split? How did Avinger's stock split work?

Avinger shares reverse split on Wednesday, January 31st 2018. The 1-40 reverse split was announced on Tuesday, January 30th 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, January 30th 2018. An investor that had 100 shares of Avinger stock prior to the reverse split would have 3 shares after the split.

What price target have analysts set for AVGR?

2 analysts have issued twelve-month target prices for Avinger's shares. Their forecasts range from $1.40 to $1.40. On average, they expect Avinger's share price to reach $1.40 in the next twelve months. This suggests a possible upside of 167.9% from the stock's current price.
View analysts' price targets for Avinger
.

Has Avinger been receiving favorable news coverage?

News coverage about AVGR stock has trended somewhat positive this week, InfoTrie reports. The research firm identifies positive and negative media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Avinger earned a media sentiment score of 1.0 on InfoTrie's scale. They also assigned news coverage about the medical device company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days.
View the latest news about Avinger
.

Are investors shorting Avinger?

Avinger saw a increase in short interest during the month of March. As of March 13th, there was short interest totaling 208,700 shares, an increase of 115.6% from the February 27th total of 96,800 shares. Based on an average daily volume of 286,900 shares, the days-to-cover ratio is currently 0.7 days.
View Avinger's Short Interest
.

Who are some of Avinger's key competitors?

What other stocks do shareholders of Avinger own?

Who are Avinger's key executives?

Avinger's management team includes the following people:
  • Mr. Jeffrey M. Soinski, Pres, CEO & Director (Age 57)
  • Mr. Mark B. Weinswig, Chief Financial Officer (Age 46)
  • Mr. Himanshu N. Patel, Chief Technology Officer (Age 59)
  • Mr. Keith Schaefer, Chief Operating Officer
  • Mr. Philip R. Preuss, VP of Marketing & Bus. Operations (Age 41)

When did Avinger IPO?

(AVGR) raised $60 million in an initial public offering (IPO) on Friday, January 30th 2015. The company issued 4,600,000 shares at a price of $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company acted as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers.

What is Avinger's stock symbol?

Avinger trades on the NASDAQ under the ticker symbol "AVGR."

How do I buy shares of Avinger?

Shares of AVGR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Avinger's stock price today?

One share of AVGR stock can currently be purchased for approximately $0.52.

How big of a company is Avinger?

Avinger has a market capitalization of $28.39 million and generates $9.13 million in revenue each year. The medical device company earns $-19,450,000.00 in net income (profit) each year or ($3.18) on an earnings per share basis.

What is Avinger's official website?

The official website for Avinger is www.avinger.com.

How can I contact Avinger?

Avinger's mailing address is 400 CHESAPEAKE DRIVE, REDWOOD CITY CA, 94063. The medical device company can be reached via phone at 650-241-7900 or via email at [email protected]

This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.